glp-1 obesity drug news oct 21 2025 Why Non-Responders Need Earlier Anti-Obesity Medication Intervention GlobalRPH Trump plan on weight loss
Description
The risk of multiple myeloma was 41% lower in those taking GLP-1 drugs compared to insulin
Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity
As the population of older adults grows and the wider clinical acceptance of therapies increases, the adoption rate is speeding up
Six providers clear that filter: Peak Wellness, Eden, Strut Health, GobyMeds, MyStart Health, and Willow
Patients should be referred to health coaches, dietitians, physiotherapists, or online weight management programmes for additional support
